1944 related articles for article (PubMed ID: 18840786)
21. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
[TBL] [Abstract][Full Text] [Related]
22. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
23. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
24. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
25. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
[TBL] [Abstract][Full Text] [Related]
26. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
27. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice.
Kamimura N; Nishimaki K; Ohsawa I; Ohta S
Obesity (Silver Spring); 2011 Jul; 19(7):1396-403. PubMed ID: 21293445
[TBL] [Abstract][Full Text] [Related]
28. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
29. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
[TBL] [Abstract][Full Text] [Related]
30. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
31. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
32. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis.
Preitner F; Mody N; Graham TE; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1420-9. PubMed ID: 19826103
[TBL] [Abstract][Full Text] [Related]
33. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
34. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
35. Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21.
Kim T; Nason S; Holleman C; Pepin M; Wilson L; Berryhill TF; Wende AR; Steele C; Young ME; Barnes S; Drucker DJ; Finan B; DiMarchi R; Perez-Tilve D; Tschöp M; Habegger KM
Diabetes; 2018 Sep; 67(9):1773-1782. PubMed ID: 29925501
[TBL] [Abstract][Full Text] [Related]
36. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
Cummings NE; Williams EM; Kasza I; Konon EN; Schaid MD; Schmidt BA; Poudel C; Sherman DS; Yu D; Arriola Apelo SI; Cottrell SE; Geiger G; Barnes ME; Wisinski JA; Fenske RJ; Matkowskyj KA; Kimple ME; Alexander CM; Merrins MJ; Lamming DW
J Physiol; 2018 Feb; 596(4):623-645. PubMed ID: 29266268
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
[TBL] [Abstract][Full Text] [Related]
38. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
[TBL] [Abstract][Full Text] [Related]
39. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
[TBL] [Abstract][Full Text] [Related]
40. Dual effects of fibroblast growth factor 21 on hepatic energy metabolism.
Samms RJ; Murphy M; Fowler MJ; Cooper S; Emmerson P; Coskun T; Adams AC; Kharitonenkov A; Ebling FJ; Tsintzas K
J Endocrinol; 2015 Oct; 227(1):37-47. PubMed ID: 26294388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
